Login to Your Account



Servier-Backed ARMGO Firm Takes on Heart Disease, More

By Randy Osborne
BioWorld Today Contributing Writer

Thursday, September 27, 2012

CEO Sapan Shah calls ARMGO Pharma Inc. "one of biotech's better-kept secrets," but news about the company has begun to leak – not unlike the faulty calcium channels in diseased tissue that ARMGO's Phase II drug candidates are designed to fix.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription